Duncker Streett & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3K | Hold |
150
| – | – | 0.01% | 313 |
|
|
2025
Q1 | $65.2K | Hold |
150
| – | – | 0.01% | 298 |
|
|
2024
Q4 | $55.3K | Sell |
150
-1,342
| -90% | -$495K | 0.01% | 316 |
|
|
2024
Q3 | $776K | Hold |
1,492
| – | – | 0.14% | 127 |
|
|
2024
Q2 | $808K | Sell |
1,492
-3,000
| -67% | -$1.63M | 0.16% | 118 |
|
|
2024
Q1 | $2.33M | Sell |
4,492
-3,000
| -40% | -$1.56M | 0.46% | 62 |
|
|
2023
Q4 | $3.53M | Sell |
7,492
-200
| -3% | -$94.3K | 0.75% | 40 |
|
|
2023
Q3 | $3.35M | Hold |
7,692
| – | – | 0.78% | 39 |
|
|
2023
Q2 | $3.42M | Hold |
7,692
| – | – | 0.76% | 40 |
|
|
2023
Q1 | $3.54M | Hold |
7,692
| – | – | 0.84% | 37 |
|
|
2022
Q4 | $3.95M | Hold |
7,692
| – | – | 0.95% | 30 |
|
|
2022
Q3 | $3.49M | Buy |
7,692
+300
| +4% | +$136K | 0.91% | 32 |
|
|
2022
Q2 | $3.57M | Buy |
7,392
+1,000
| +16% | +$483K | 0.85% | 35 |
|
|
2022
Q1 | $3.14M | Buy |
6,392
+4,795
| +300% | +$2.36M | 0.62% | 47 |
|
|
2021
Q4 | $740K | Sell |
1,597
-6,070
| -79% | -$2.81M | 0.13% | 147 |
|
|
2021
Q3 | $2.86M | Sell |
7,667
-93
| -1% | -$34.7K | 0.54% | 58 |
|
|
2021
Q2 | $2.96M | Hold |
7,760
| – | – | 0.55% | 60 |
|
|
2021
Q1 | $2.79M | Buy |
7,760
+455
| +6% | +$163K | 0.53% | 64 |
|
|
2020
Q4 | $2.35M | Buy |
7,305
+205
| +3% | +$65.8K | 0.45% | 71 |
|
|
2020
Q3 | $1.91M | Buy |
7,100
+130
| +2% | +$34.9K | 0.42% | 78 |
|
|
2020
Q2 | $1.83M | Hold |
6,970
| – | – | 0.44% | 76 |
|
|
2020
Q1 | $1.58M | Buy |
6,970
+3,970
| +132% | +$901K | 0.42% | 79 |
|
|
2019
Q4 | $906K | Buy |
+3,000
| New | +$906K | 0.19% | 128 |
|